Apollon Financial’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.5K Buy
+11,258
New +$37.8K ﹤0.01% 309

Other funds holding ELDN

Apollon Financial's ELDN Position: Q3 2026 in Review

Apollon Financial opened a new position in Eledon Pharmaceuticals (ELDN) in Q3 2026: 11,258 shares worth $28.5K. The stake represents ﹤0.01% of the portfolio and ranks #309 among its holdings.

155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Apollon Financial held 11,258 shares of Eledon Pharmaceuticals worth $28.5K as of Q3 2026.
  • Eledon Pharmaceuticals was a new Apollon Financial position in Q3 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Apollon Financial's portfolio in Q3 2026, its #309 holding.
  • 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Apollon Financial's 13F filing for Q3 2026, filed 23 Oct 2026.